- Active not recruitingPHASE2
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
This study looks at a new drug, ALXN2030, to help people who have had a kidney transplant and are now experiencing a problem called antibody-mediated rejection (AMR). We want to see if the drug can help the kidney recover.
For: Antibody-Mediated Rejection · Kidney Transplantation · Biopsy-proven Histologic ScoresUnited States · Brazil · Canada - Active not recruitingPHASE1
Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
This study is looking into a new medication called ALXN2030. We want to check how safe it is and if it causes any side effects in healthy people. We're also seeing how the body handles the medicine. It's an early-stage study to gather important safety information.
For: HealthyUnited Kingdom